The use of botulinum toxin in the treatment of headaches

Pain Physician

Volumn 7, Issue 3, 2004, Pages 377-387

  Mauskop, Alexander ^a  

^a New York Headache Center   (United States)

Author keywords

Botulinum toxin; Headache; Headache management; Migraine; Tension type headache

Indexed keywords

ACETYLSALICYLIC ACID; ADRENERGIC RECEPTOR STIMULATING AGENT; ANALGESIC AGENT; ANTIMIGRAINE AGENT; BOTULINUM TOXIN; BOTULINUM TOXIN A; BOTULINUM TOXIN B; CAFFEINE; CODEINE; DICHLORALPHENAZONE; DIGLYCINE; IBUPROFEN; ISOMETHEPTENE MUCATE; LIDOCAINE; MAGNESIUM CHLORIDE; MAGNESIUM DERIVATIVE; MAGNESIUM OXIDE; MAGNESIUM SULFATE; METHYLPREDNISOLONE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PLACEBO; PLANT EXTRACT; RIBOFLAVIN; SECBUTABARBITAL; TANACETUM PARTHENIUM EXTRACT; TOXIN ANTIBODY; UBIDECARENONE; UNINDEXED DRUG; VASOACTIVE AGENT;

ACUPUNCTURE; BLEPHAROSPASM; CHRONIC PAIN; CLINICAL TRIAL; DIARRHEA; DROWSINESS; DRUG ABSORPTION; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRUG TOLERABILITY; ESTHETICS; FEEDBACK SYSTEM; HEADACHE; HUMAN; INJECTION PAIN; MEDICAL SPECIALIST; MIGRAINE; MOTOR DYSFUNCTION; NECK MUSCLE; PROPHYLAXIS; PTOSIS; QUALITY OF LIFE; REBOUND; REVIEW; SEDATION; SOMNOLENCE; TACHYPHYLAXIS; TANACETUM PARTHENIUM; TENSION HEADACHE; TORTICOLLIS; UNITED STATES; XEROSTOMIA;

EID: 4444260268     PISSN: 15333159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (79)

1. Erbguth FJ, Naumann, M. Historical aspects of botulinum toxin. Justinius Kerner (1786-1862) and the "sausage poison". Neurology 1999; 53:1850-1853.
2. Sloop RR, Cole BA, Escutin RO. Human response to botulinum toxin injection: Type B compared with type A. Neurology 1997; 49:189-194.
3. Jankovic J, Schwartz K. Botulinum toxin injections for cervical dystonia. Neurology 1990; 40:277-280.
4. Foster L, Clapp L, Erickson M et al. Botulinum toxin A and chronic low back pain. A randomized, double-blind study. Neurology 2001; 56:1290-1293.
5. Binder WJ, Brin MF, Blitzer A et al. Botulinum toxin type A (BOTOX) for treatment of migraine headaches: an open-label study. Otolaryngol Head Neck Surg 2000; 123:669-676.
6. Giladi N. The mechanism of action of botulinum toxin type A in focal dystonia is most probably through its dual effect on efferent (motor) and afferent pathways at the injected site. J Neurol Sci 1997; 152:132-135.
7. Aoki KR. Evidence for antinociceptive activity of botulinum toxin type A in pain management. Headache. 2003; 43:S9-S15.
8. Göbel H, Heinze A, Heinze-Kuhn K et al. Botulinum toxin A in the treatment of headache syndromes and pericranial pain syndromes. Pain 2001; 91:195-199.
9. Göbel H, Lindner V, Krack P et al. Treatment of chronic tension-type headache with botulinum toxin [abstract]. Cephalalgia 1999; 19:455.
10. Smuts JA, Barnard PWA. Botulinum toxin type A in the treatment of headache syndromes: a clinical report of 79 patients [abstract]. Cephalalgia 2000; 20:332.
11. Mauskop A, Basdeo R. Botulinum toxin A is an effect prophylactic therapy of migraines [abstract]. Cephalalgia 2000; 20:422.
12. Mauskop A. Long-term use of botulinum toxin type A in the treatment of episodic and chronic migraine headaches [abstract]. Headache 2002; 42:454-455.
13. Mauskop A. The use of botulinum toxin in the treatment of headaches. Curr Pain Headache Rep 2002; 6:320-323.
14. Brin MF, Swope DM, O'Brian C et al. Botox for migraine: Double-bind, placebo-controlled region-specific evaluation [abstract]. Cephalalgia 2000; 20:421-422.
15. Krack P. Hornig C, Dorndorf W. Resolution of chronic tension headache after botulinum toxin treatment of idiopathic blepharospasm. Mov Disord 1995; 10:388.
16. Schulte-Mattler WJ, Wieser T et al. Treatment of tension-type headache with botulinum toxin: a pilot study. Eur J Med Res 1999; 4:183-186.
17. Relja MA. Treatment of tension-type headache with botulinum toxin: 1-year follow up [abstract]. Cephalalgia 2000; 20:336.
18. Relja MA. Treatment of tension-type headache by injection of botulinum toxin type A: double blind placebo-controlled study. Eur J Neurol 1997; 4:S71-S73.
19. Relja MA, Klepac N. Botulinum toxin type A as a prophylactic treatment for chronic tension type headache: long term follow up study [abstract]. Neurology 2001; 56:A203.
20. Rollnik JD, Tanneberger O, Schubert M et al. Treatment of tension-type headache with botulinum toxin type A: A double-blind, placebo-controlled study. Headache 2000; 40:300-305.
21. Freund BJ, Schwartz M. Treatment of chronic cervical-associated headache with botulinum toxin A: A pilot study. Headache 2000; 40:231-236.
22. Hobson DE, Gladish DF. Botulinum toxin injection for cervicogenic headache. Headache 1997; 37:253-255.
23. Klapper JA, Mathew NT, Mapper A et al. Botulinum toxin type A (BT-A) for the prophylaxis of chronic daily headache [abstract]. Cephalalgia 2000; 20:291-292.
24. Klapper JA, Klapper A. Use of botulinum toxin in chronic daily headaches associated with migraine. Headache Quart 1999; 10:141-143.
25. Klapper J, Mathew N. Botulinum toxin type A (BTX-A) for the prophylaxis of chronic daily headache [abstract]. Cephalalgia 2000; 20:292-293.
26. Freund B, Schwartz M. The use of botulinum toxin A in the treatment of refractory cluster headache: case reports [abstract]. Cephalalgia 2000; 20:329-330.
27. Ginies PR, Fraimout JL, Kong A et al. Treatment of cluster headache by subcutaneous injection of botulinum toxin. Program and abstracts of the 8th World Congress on Pain. 1996. Abstract 50.
28. Silberstein S, Mathew N, Saper J et al. Botulinum toxin type A as a migraine preventive treatment. Headache 2000; 40:445-450.
29. Blumenfeld AM. Impact of botulinum toxin type A treatment on medication costs and usage in difficult-to- treat chronic headache: case studies. Headache Quar 2001; 12:241-244.
30. Relja MA. Botulinum toxin type-A reduces acute medication (triptans) use in migraine patients [abstract]. Neurology 2003; 60:147.
31. Poungvarin N. The first world report of botulinum A toxin injection for status migrainosus. J Med Assoc Thai 2001; 84:1199-1203.
32. Blumenfeld A. Botulinum toxin type A as an effective preventive treatment in headache [abstract]. Headache 2003; 43:576.
33. Mathew N, Kaup A, Kailasam J. Botulinum toxin type A modifies chronic migraine; further long-term (3 years) experience with up to ten sets of treatments [abstract]. Headache 2003; 43:576.
34. Barrientos N, Chana P. Efficacy and safety of botulinum toxin type A (BOTOX) in the prophylactic treatment of migraine [abstract]. Headache 2002; 42:452.
35. Eross EJ, Dodick DW. The effects of botulinum toxin type A on disability in episodic and chronic migraine [abstract]. Neurology 2002; 58:A497.
36. Krusz J. Intradermal botulinum toxin, type A, for cervicogenic migraine [abstract]. Headache 2002; 42:405.
37. Smuts JA, Baker MK, Smuts HM et al. Prophylactic treatment of chronic tension-type headache using botulinum toxin type A. Eur J Neurol 1999; 6:S99-S102.
38. Freund BJ, Schwartz M. Treatment of whiplash associated neck pain [corrected] with botulinum toxin-A: a pilot study. J Rheumatol 2000; 27:481-484.
39. Porta M. A comparative trial of botulinum toxin type A and methylprednisolone for the treatment of tension-type headache. Curr Rev Pain 2000; 4:31-35.
40. McAllister P. Patient- reported improvements in headache and change in headache medication usage in a cohort treated with botulinum toxin type-A (Botox) [abstract]. Headache 2003; 43:577.
41. Tepper SJ, Bigal ME, Sheftell FD et al. The effect of botulinum toxin on the disability of refractory headaches [abstract]. Headache 2003; 43:578.
42. Miller T, Denny L. Botulinum toxin A (Allergan) for chronic intractable headache: equally effective with or without concomitant neck pain [abstract). Headache 2003; 43:579.
43. Tomosovic J, Sabo T. Improvement of intractable headache in adolescent females after craniocervical injections of BTX-A (Allergan) [abstract]. Headache. 2003; 43:579.
44. Loder E. Botulinum toxin treatment of headache and neck pain associated with stiff-person syndrome [abstract]. Headache 2003; 43:509.
45. Troost T, Rosenberg JR, Wiles R. Improvement in intractable headache with repeated botulinum toxin type A treatment [abstract]. Neurology 2003;60:A323-A324.
46. Wheeler AH. Botulinum toxin A, adjunctive therapy for refractory headaches associated with pericranial muscle tension. Headache 1998; 38:468-471.
47. Sebastian FT, de Bruijn M. Treatment of chronic tension-type headache with botulinum toxin; a double-blind placebo controlled clinical trial [abstract]. Neurology 2003; 60:148.
48. Blumenfeld AM. Botulinum toxin type A (BOTOX®) as an effective prophylactic treatment in headache [abstract]. Cephalalgia 2002; 22:20.
49. Troost BT. Botulinum toxin type A (BOTOX) therapy for intractable headache [abstract]. Headache 2002; 42:435-436.
50. Padberg M, De Bruijn SJ. Treatment of chronic tension-type headache with botulinum toxin: A double-blind, placebo-controlled clinical trial [abstract]. Neurol 2002; 1:63.
51. Ondo WG, Derman HS. Botulinum toxin type A (BOTOX®) for chronic daily headache: A 60 subject, randomized, placebo-controlled, parallel design study [abstract]. Headache 2002; 42;431.
52. Lopez-Lozano LL. Clinical study of the value of botulinum toxin-A (Botox) in the treatment of chronic tension-type headache with associated pericranial muscle tenderness [abstract]. Cephalalgia 2002; 22:32-33.
53. Lin JJ, Chang DC. Efficient treatment of chronic tension-type headache with botulinum toxin-A [abstract]. Cephalalgia. 2002; 22:15-16.
54. Miller T, Denny L. Retrospective cohort analysis of 48 chronic headache patients treated with botulinum toxin type A (BOTOX) in a combination fixed-injection -site and "follow the pain" protocol [abstract]. Headache 2002; 42:430-431.
55. Edwards KR. Botulinum toxin type A (Botox) for chronic daily headaches [abstract]. Headache 2002; 42:429.
56. Freund BJ, Schwartz M. Treatment of whiplash associated neck pain with botulinum toxin-A: report of 8 cases. J Rheumatol 1999; 26:756-775.
57. Woliina U. Botulinum A toxin for wrinkles: release from tension headache.J Eur Acad Dermatol Venereol 2000; 14:142-143.
58. Johnstone,SJ, Adler CH. Headache and facial pain responsive to botulinum toxin: an unusual presentation of blepharospasm. Headache 1998; 38:366-368.
59. Silberstein SD. Review of botulinum toxin type A and its clinical applications in migraine headache. Expert Opin Pharmacother 2001; 2:1649-1654.
60. Royal MA. The use of botulinum toxins in the management of pain and headache. Pain Pract 2001; 1:215-235.
61. Mathew NT; Kaup AO. The use of botulinum toxin type A in headache treatment Curr Treat Options Neurol 2002; 4:365-373.
62. Chapman SL. A review and clinical perspective on the use of EMG and thermal biofeedback for chronic headaches. Pain 1986; 27:1-43.
63. Blanchard EB. Long term effects of behavioral treatment or chronic headache. Behav Ther 1987; 8:375-385.
64. Gauthier JG, Carrier S. Long-term effects of biofeedback on migraine headache: A prospective follow-up study. Headache 1991; 31:605-612.
65. Mauskop A, Altura BT, Cracco RQ et al. Intravenous magnesium sulfate relieves migraine attacks in patients with low serum ionized magnesium levels: a pilot study. Clin Science 1995; 89:633-636.
66. Facchinetti F, Sances G, Borella P et al. Magnesium prophylaxis of menstrual migraine: effects on intracellular magnesium. Headache 1991; 31:298-301.
67. Peikert A, Wilimzig C, Kohne-Volland R. Prophylaxis of migraine with oral magnesium: results from a prospective, multicenter, placebo-controlled and double-blind randomized study. Cephalalgia 1996; 16:257-263.
68. Pfaffenrath V, Wessely P, Meyer C, et al. Magnesium in the prophylaxis of migraine: a double-blind, placebo-controlled study. Cephalalgia 1996; 16:436-440.
69. Schoenen J, Jacquy J, Lenaerts M. Effectiveness of high-dose riboflavin in migraine prophylaxis. Neurology 1998; 50:466-470.
70. 10 for migraine prophylaxis: a randomized trial [abstract]. Cephalalgia 2003; 23:577.
71. Vogler BK, Pittler MH, Ernst E. Feverfew as a preventive treatment for migraine: a systematic review. Cephalalgia 1998; 18:704-708.
72. Murphy JJ, Heptinsall S, Mitchell JRA. Randomized double-blind placebo-controlled trial of feverfew in migraine prevention. Lancet 1988; 2:189-192.
73. Pfaffenrath V, Diener HC, Fischer M et al. The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis - a double-blind, multicentre, randomized placebo-controlled dose-response study. Cephalalgia 2002; 22:523-532.
74. Grossman M, Schmidramsl H. An extract of Petasites hybridus is effective in the prophylaxis of migraine. Int J Clin Pharmacol Ther 2000; 38:430-435.
75. Lipton RB, Gobel H, Wilks K et al. Efficacy of petasites (an extract from petasites rhizone) 50 and 75 mg for prophylaxis of migraine: results of a randomized, double-blind, placebo-controlled study. Neurology 2002; 58:A472.
76. Han JS, Terenius L. Neurochemical basis of acupuncture analgesia. Ann Rev Pharmocol Toxicol 1982; 22:193-220.
77. Melchart D, Linde K, Fischer P, et al. Acupuncture for recurrent headaches: a systematic review of randomized controlled trials. Cephalalgia 1999; 19:779-786.
78. Ferrari MD, Roon KI, Lipton RB et al. Oral triptans in acute migraine treatment: A meta-analysis of 53 trials. Lancet 2001; 358:1668-1675.
79. 2+ ratio. Headache 1993; 33:135-138.